NCT06214988

Brief Summary

The goal of this observational trial with a nested randomized controlled trial is to investigate a selective approach of defunctioning stoma in low anterior resection in rectal cancer patients. The primary outcome is a hybrid so-called textbook outcome; stoma-free survival at two years without major LARS, reflecting a functionally appropriate outcome after low anterior resection for rectal cancer. Secondary outcomes include anastomotic leakage, postoperative mortality, reinterventions, stoma-related complications, quality of life measures, LARS, and permanent stoma rate up to two years after index surgery.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
212

participants targeted

Target at P75+ for not_applicable

Timeline
57mo left

Started Sep 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress27%
Sep 2024Dec 2030

First Submitted

Initial submission to the registry

December 17, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 22, 2024

Completed
7 months until next milestone

Study Start

First participant enrolled

September 1, 2024

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2030

Last Updated

May 21, 2025

Status Verified

May 1, 2025

Enrollment Period

3.3 years

First QC Date

December 17, 2023

Last Update Submit

May 15, 2025

Conditions

Keywords

anterior resectiondefunctioning stomaselective approach

Outcome Measures

Primary Outcomes (1)

  • textbook outcome; stoma-free survival at two years without major LARS

    extant stoma, alive, and a LARS score at 30 or lesn has stabilised as well for those without a stoma in situ. no extant stoma, alive, and a LARS score at 30 or less at the time point two years after the anterior resection.

    2 year

Secondary Outcomes (14)

  • Anastomotic leakage

    1,3,12 and 24 months

  • Complications

    1,3,12 and 24 months

  • Length of hospital stay

    until discharge within 90 days

  • Postoperative mortality

    3 months

  • Major Low Anterior Resection Syndrome

    12 and 24 months

  • +9 more secondary outcomes

Study Arms (2)

selective approach to defunctioning stoma

EXPERIMENTAL

With randomisation to this experimental arm (selective approach), no defunctioning stoma is constructed.

Procedure: selective approach defunctioning stoma

routine use of defunctioning stoma

NO INTERVENTION

With randomisation to this control arm (systematic approach), a defunctioning stoma is constructed using the marked stoma site. A loop ileostomy is fashioned using an ileal loop close to the ileocecal valve, while a loop colostomy can be derived from either the transverse or a redundant left colon.

Interventions

With randomisation to this experimental arm (selective approach), no defunctioning stoma is constructed.

selective approach to defunctioning stoma

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients with rectal cancer planned for a low anterior resection with anastomosis by TME with any surgical approach
  • Patients aged less than 80 years
  • Patients with American Society of Anesthetists' (ASA) fitness grade I or II as determined by the anaesthesiologist or the surgeon
  • Anastomotic leak risk score of 0-1
  • Willingness to be randomised

You may not qualify if:

  • Insufficient command of Swedish, Norwegian, Danish or English to understand questionnaires or consent
  • Emergency rectal resection (tumour resection due to large bowel obstruction, perforation, etc)
  • Previous pelvic irradiation (due to e.g. gynaecological or urological cancer)
  • Preoperative tumour perforation or pelvic sepsis
  • Beyond TME surgery and/or concurrent resection of other organ
  • Concurrent corticosteroid treatment (prednisone-equivalent dosage ≥10 mg daily)
  • Planned postoperative chemotherapy
  • Smoking not completely ceased four weeks before surgery
  • \>2 staple firings for rectal transection
  • Intraoperative blood loss ≥250 ml for minimally invasive surgery
  • Intraoperative blood loss ≥500 ml for open or converted surgery
  • More than one intraabdominal anastomosis performed
  • Incomplete doughnuts
  • Air-leak test positive
  • Any significant intraoperative adverse event at the discretion of the operating surgeon (e.g. ureterotomy, bowel or tumour perforation, major medical event - pulmonary embolism, cardiac arrhythmia) (Gawria, 2022)
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Skåne University Hospital

Malmo, Sweden

RECRUITING

Related Publications (1)

  • Rutegard M, Lindskold M, Jorgren F, Landerholm K, Matthiessen P, Forsmo HM, Park J, Rosenberg J, Schultz J, Seeberg LT, Segelman J, Buchwald P. SELective defunctioning Stoma Approach in low anterior resection for rectal cancer (SELSA): Protocol for a prospective study with a nested randomized clinical trial investigating stoma-free survival without major LARS following total mesorectal excision. Colorectal Dis. 2025 Feb;27(2):e70009. doi: 10.1111/codi.70009.

MeSH Terms

Conditions

Rectal Neoplasms

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • Pamela Buchwald, MD PhD

    Skåne University Hospital, Lund University

    PRINCIPAL INVESTIGATOR
  • Martin Rutegård, MD PhD

    Umeå University Hospital, Umeå University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Caroline Nilsson, RN

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Observational trial with nested randomized trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor, senior consultant surgeon

Study Record Dates

First Submitted

December 17, 2023

First Posted

January 22, 2024

Study Start

September 1, 2024

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2030

Last Updated

May 21, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

Unidentified raw data may be shared upon request.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
When study complete including primary and secondary endpoints.

Locations